Medical Design and Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech

HeartWare International, Inc. Announces Pricing of Concurrent Public Offerings of Convertible Senior Notes and Common Stock

December 10, 2010 By Bio-Medicine.Org

FRAMINGHAM, Mass. and SYDNEY, Dec. 10, 2010
/PRNewswire-FirstCall/ — HeartWare International, Inc. (Nasdaq:
HTWR, ASX: HIN) (“HeartWare”) announced today the pricing of a
public offering of $125 million principal amount of convertible
senior notes due 2017 (the “notes”) pursuant to an effective shelf
registration statement filed with the Securities and Exchange
Commission (“SEC”) yesterday.  HeartWare announced today that
it increased its previously announced offering of convertible
senior notes due 2017 to $125 million in aggregate principal
amount.  HeartWare also granted the underwriters an option to
purchase up to an additional $18.75 million principal amount of
convertible notes to cover over-allotments, if any.  

The notes will bear interest at a rate of 3.50% per annum and
will mature on December 15, 2017.  The notes will be
convertible upon the occurrence of certain events and during
specified periods.  Upon conversion, HeartWare will pay or
deliver, as the case may be, cash, shares of HeartWare’s common
stock or a combination thereof, at HeartWare’s option.  

The initial conversion rate will be 10.0000 shares of common
stock per $1,000 principal amount of notes, which corresponds to an
initial conversion price of $100.00, representing a conversion
premium of approximately 23% based on the closing price of $81.31
on December 9, 2010.  The conversion rate is subject to
adjustment from time to time upon the occurrence of certain events.
 

The Company also announced the pricing of a concurrent public
offering of 900,000 shares of HeartWare’s common stock held by
Apple Tree Partners I, L.P., one of HeartWare’s existing
stockholders, at a price per share of $81.31 pursuant to an
effective shelf registration statement filed with the SEC
yesterday.  Apple Tree Partners I, L.P. has also granted the
underwriters an option to purchase up to 100,000 additional shares
to cover over-allotments, if any.

‘/>”/>

SOURCE

Related Articles Read More >

Johnson & Johnson Office of Digital Innovation Leader Peter Schulam
Imagining the future of cloud-connected medical devices with Johnson & Johnson leaders
Withings Body Scan
Withings plans launch for Body Scan smart scale platform
BinaxNow COVID-19 Ag Card
Time recognizes Abbott offerings among this year’s 100 best inventions
Koya Medical’s Dayspring device
Koya Medical reports positive early results in Dayspring lymphedema trial

DeviceTalks Weekly.

May 20, 2022
DeviceTalks Boston Post-Game – Editors’ Top Moments, Insulet’s Eric Benjamin on future of Omnipod 5
See More >

MDO Digital Edition

Digital Edition

Subscribe to Medical Design & Outsourcing. Bookmark, share and interact with the leading medical design engineering magazine today.

MEDTECH 100 INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
DeviceTalks

DeviceTalks is a conversation among medical technology leaders. It's events, podcasts, webinars and one-on-one exchanges of ideas & insights.

DeviceTalks

New MedTech Resource

Medical Tubing

Enewsletter Subscriptions

Enewsletter Subscriptions

MassDevice

Mass Device

The Medical Device Business Journal. MassDevice is the leading medical device news business journal telling the stories of the devices that save lives.

Visit Website
MDO ad
Medical Design and Outsourcing
  • MassDevice
  • DeviceTalks
  • MedTech 100 Index
  • Medical Tubing + Extrusion
  • Drug Delivery Business News
  • Drug Discovery & Development
  • Pharmaceutical Processing World
  • R&D World
  • About Us/Contact
  • Advertise With Us
  • Subscribe to Print Magazine
  • Subscribe to E-newsletter
  • Attend our Monthly Webinars
  • Listen to our Weekly Podcasts
  • Join our DeviceTalks Tuesdays Discussion

Copyright © 2022 WTWH Media, LLC. All Rights Reserved. Site Map | Privacy Policy | RSS

Search Medical Design & Outsourcing

  • Home
  • Medical Device Business
    • Mergers & Acquisitions
    • Financial
    • Regulatory
  • Applications
    • Cardiovascular
    • Devices
    • Imaging
    • Implantables
    • Medical Equipment
    • Orthopedic
    • Surgical
  • Technologies
    • Contract Manufacturing
    • Components
    • Electronics
    • Extrusions
    • Materials
    • Motion Control
    • Prototyping
    • Pumps
    • Tubing
  • Med Tech Resources
    • DeviceTalks Tuesdays
    • Digital Editions
    • eBooks
    • Manufacturer Search
    • Medical Device Handbook
    • MedTech 100 Index
    • Podcasts
    • Print Subscription
    • The Big 100
    • Webinars / Digital Events
    • Whitepapers
    • Video
  • 2022 Leadership in MedTech
    • 2022 Leadership Voting!
    • 2021 Winners
    • 2020 Winners
  • Women in Medtech